Abstract:The ever-growing drug resistance problem worldwide highlights the urgency to discover and develop new drugs. Microbial natural products are a prolific source of drugs. Genome sequencing has revealed a tremendous amount of uncharacterized natural product biosynthetic gene clusters (BGCs) encoded within microbial genomes, most of which are cryptic or express at very low levels under standard culture conditions. Therefore, developing effective strategies to awaken these cryptic BGCs is of great interest for natural product discovery. In this study, we designed and validated a Transcription–Translation in One (TTO) approach for activation of cryptic BGCs. This approach aims to alter the metabolite profiles of target strains by directly overexpressing exogenous rpsL (encoding ribosomal protein S12) and rpoB (encoding RNA polymerase β subunit) genes containing beneficial mutations for natural product production using a plug-and-play plasmid system. As a result, this approach bypasses the tedious screening work and overcomes the false positive problem in the traditional ribosome engineering approach. In this work, the TTO approach was successfully applied to activating cryptic BGCs in three Streptomyces strains, leading to the discovery of two aromatic polyketide antibiotics, piloquinone and homopiloquinone. We further identified a single BGC responsible for the biosynthesis of both piloquinone and homopiloquinone, which features an unusual starter unit incorporation step. This powerful strategy can be further exploited for BGC activation in strains even beyond streptomycetes, thus facilitating natural product discovery research in the future.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acschembio.0c00581?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acschembio.0c00581</a>.Methods and materials, including strains, plasmids, chemicals, strain manipulation, cultivation and fermentation conditions, isolation and characterization of natural products from activated biosynthetic pathways, bioactivity assay, genome sequencing, gene overexpression and gene deletions (<a class="ext-link" href="/doi/suppl/10.1021/acschembio.0c00581/suppl_file/cb0c00581_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

Yeast homologous recombination-based promoter engineering for the activation of silent natural product biosynthetic gene clusters

Yeast homologous recombination-based promoter engineering for the activation of silent natural product biosynthetic gene clusters

Recent advances in activating silent biosynthetic gene clusters in bacteria

Promoter engineering of natural product biosynthetic gene clusters in actinomycetes: concepts and applications

Recent Advances in Silent Gene Cluster Activation in Streptomyces

A Versatile Transcription–Translation in One Approach for Activation of Cryptic Biosynthetic Gene Clusters

Unlocking the trove of metabolic treasures: activating silent biosynthetic gene clusters in bacteria and fungi

Promoter Activation in Δhfq Mutants As an Efficient Tool for Specialized Metabolite Production Enabling Direct Bioactivity Testing.

High-throughput platform for the discovery of elicitors of silent bacterial gene clusters

Exploiting A Precise Design Of Universal Synthetic Modular Regulatory Elements To Unlock The Microbial Natural Products In Streptomyces

New strategies for drug discovery: activation of silent or weakly expressed microbial gene clusters

CRAGE Enables Rapid Activation of Biosynthetic Gene Clusters in Undomesticated Bacteria.

CRISPR–Cas9 strategy for activation of silent Streptomyces biosynthetic gene clusters

Recent Advances in Strategies for Activation and Discovery/Characterization of Cryptic Biosynthetic Gene Clusters in Streptomyces

Genome mining-directed activation of a silent angucycline biosynthetic gene cluster in Streptomyces chattanoogensis.

Recent advances in heterologous expression of natural product biosynthetic gene clusters in Streptomyces hosts

Discovery of microbial natural products by activation of silent biosynthetic gene clusters

Discovery, characterization, and engineering of an advantageous Streptomyces host for heterologous expression of natural product biosynthetic gene clusters

Manipulating Natural Product Biosynthetic Pathways Via DNA Assembler